Randomised crossover trial to evaluate the effects of Zileuton in patients with Sjogren-Larsson syndrome assessing potential benefit in terms of symptoms (itch), biochemical and neuropsychological indices
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Zileuton (Primary)
- Indications Sjogren-Larsson syndrome
- Focus Therapeutic Use
- 29 Jun 2016 New trial record